Cardiolipin-binding peptide studied in mitochondrial-function models.
For research use only. Not for human or veterinary use. No claims of safety, efficacy or therapeutic benefit.
Cardiolipin-associated mitochondrial membrane research; energy production and oxidative stress. In MMPOWER-3, elamipretide did not significantly improve the primary walking-distance or fatigue endpoints in primary mitochondrial myopathy.
Clinical findings apply to the studied formulation, population and indication. They do not establish equivalence, safety or therapeutic efficacy of this research product.
PMID: 37268435
Contact the Avitus team to confirm available presentations, product specifications and pricing for your research requirements.